Table 3. Expression data of verified miRNAs in verified samples.
| Systematic name | Group 1† (mean ± SD) | Group 2§ (mean ± SD) | Expression tendency | P value | Consistency with microarray data |
|---|---|---|---|---|---|
| miR-19a-3p | 2.7755±1.9353 | 4.3625±2.4464 | Up | 0.0142 | Consistent |
| miR-17-3p | 11.5405±7.1147 | 20.8601±11.6442 | Up | 0.0015 | Consistent |
| miR-18b-5p | 3.8370±3.5448 | 7.4825±4.7258 | Up | 0.0034 | Consistent |
| miR-4440 | 15.0672±9.7576 | 28.5884±12.8204 | Up | 0.0001 | Inconsistent |
| miR-6127 | 1.8697±2.4215 | 7.0070±10.2709 | Up | 0.0219 | Inconsistent |
| miR-18a-5p | 11.8070±17.2393 | 15.4644±12.1872 | Up | 0.3907 | Consistent |
| miR-4728-5p | 12.1957±8.2501 | 10.1191±5.7729 | Down | 0.3077 | Consistent |
| miR-301a-3p | 4.0238±5.3562 | 6.0518±4.9430 | Up | 0.1706 | Consistent |
| miR-1587 | 2.8291±4.4520 | 2.0499±3.4587 | Down | 0.4929 | Consistent |
| miR-6779-5p | 11.1996±15.6308 | 6.5792±9.1691 | Down | 0.2100 | Consistent |
| miR-1249-5p | 11.5868±25.2595 | 1.9651±2.0145 | Down | 0.0696 | Consistent |
| miR-25-3p | 5.8477±7.8516 | 5.9716±15.2436 | Up | 0.9713 | Consistent |
| miR-590-5p | 1.7158±1.9584 | 1.9663±3.1066 | Up | 0.7346 | Consistent |
| miR-106b-5p | 3.1245±3.8459 | 5.2519±5.1641 | Up | 0.1056 | Consistent |
| miR-1290 | 1.4002±1.2459 | 1.1800±1.3934 | Down | 0.5588 | Consistent |
| miR-93-5p | 2.4981±1.8751 | 4.1980±3.9970 | Up | 0.0626 | Consistent |
| miR-197-5p | 3.0791±4.4242 | 7.5768±11.3776 | Up | 0.0750 | Inconsistent |
| miR-17-5p | 3.8699±6.0198 | 3.1352±2.3148 | Down | 0.5716 | Inconsistent |
| miR-20a-5p | 2.3972±4.5983 | 1.5096±1.1455 | Down | 0.3537 | Inconsistent |
†, Group 1: expression levels of miRNAs in cancer tissues without lymph node metastasis; §, Group 2: expression levels of miRNAs in cancer tissues with lymph node metastasis.